Zealand Pharma AS (OTCPK:ZLDPF)
$ 42.89 (0%) Market Cap: 3.02 Bil Enterprise Value: 847.50 Mil PE Ratio: 3.17 PB Ratio: 1.38 GF Score: 62/100

Zealand Pharma A/S at Barclays Global Healthcare Conference Transcript

Mar 11, 2026 / 06:00PM GMT
Release Date Price: $39.79
Yihan Li
Barclays Services Corp - Equity Analyst

Hey. Good afternoon, everyone. I'm Yihan Li, Barclays European Biopharma after research analyst. Today, it is my pleasure to host Zealand Pharma, a fire chat with Adam Steensberg, the CEO of Zealand.

So thank you for joining us today, and we are delighted to have you here to walk us through your story. So actually, to start it, I will hand it over to you, Adam, to have a brief introduction of Zealand and do some presentation.

Adam Steensberg;S;President
Zealand Pharma A;Chief Executive Officer, Member of the Executive Management

/- -

Absolutely a pleasure to be here. So Zealand Pharma, we are here to address what we believe is the biggest health care challenge of our time and that's the obesity pandemic and all the diseases that follows the obesity pandemic, you can actually ascribe more than 220 diseases to the increase in obesity that we see these years. And we need to do something about this as a society. So transforming the future of metabolic health, that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot